FI883064A0 - Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi

Info

Publication number: FI883064A0
Authority: FI; Finland
Prior art keywords: preparation; heterocyclic compounds; therapeutically useful; useful heterocyclic; therapeutically
Prior art date: 1987-06-24

Application number

FI883064A

Other languages

English (en)

Swedish (sv)

Other versions

FI93356B (fi

FI883064A (fi

FI93356C (fi

Inventor

Klaus Peter Bogeso

Klaus Gundertofte Jensen

Ejner Knud Moltzen

Henrik Pedersen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-24

Filing date

1988-06-23

Publication date

1988-06-23

1988-06-23 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

1988-06-23 Publication of FI883064A0 publication Critical patent/FI883064A0/fi

1988-12-25 Publication of FI883064A publication Critical patent/FI883064A/fi

1994-12-15 Publication of FI93356B publication Critical patent/FI93356B/fi

1995-03-27 Application granted granted Critical

1995-03-27 Publication of FI93356C publication Critical patent/FI93356C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FI883064A 1987-06-24 1988-06-23 Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi FI93356C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8714789		1987-06-24
GB878714789A GB8714789D0 (en)	1987-06-24	1987-06-24	Heterocyclic compounds

Publications (4)

Publication Number	Publication Date
FI883064A0 true FI883064A0 (fi)	1988-06-23
FI883064A FI883064A (fi)	1988-12-25
FI93356B FI93356B (fi)	1994-12-15
FI93356C FI93356C (fi)	1995-03-27

Family

ID=10619472

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI883064A FI93356C (fi)	1987-06-24	1988-06-23	Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi

Country Status (19)

Country	Link
US (3)	US4866077A (fi)
EP (1)	EP0296721B1 (fi)
JP (1)	JP2703268B2 (fi)
AU (1)	AU615917B2 (fi)
BR (1)	BR1100658A (fi)
CA (1)	CA1340458C (fi)
DE (1)	DE3881970T2 (fi)
DK (1)	DK168600B1 (fi)
ES (1)	ES2056928T3 (fi)
FI (1)	FI93356C (fi)
GB (1)	GB8714789D0 (fi)
HK (1)	HK84194A (fi)
HU (1)	HU210809A9 (fi)
IE (1)	IE61694B1 (fi)
IL (1)	IL86618A (fi)
NO (1)	NO174051C (fi)
NZ (1)	NZ224868A (fi)
PT (1)	PT87820B (fi)
ZA (1)	ZA884339B (fi)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3877470T2 (de) *	1987-09-10	1993-06-24	Merck Sharp & Dohme	Oxazole und thiazole zur behandlung seniler demenz.
IE63906B1 (en) *	1987-11-13	1995-06-14	Novo Nordisk As	Azabicyclic compounds and their preparation and use
EP0330353B1 (en) *	1988-02-19	1993-04-07	Eli Lilly And Company	Tetrazole excitatory amino acid receptor antagonists
DK162892C (da) *	1988-07-04	1992-05-11	Novo Nordisk As	1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
IT1229491B (it) *	1988-12-28	1991-09-03	Roussel Maestretti S P A Ora R	Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
JP3003148B2 (ja) *	1989-01-05	2000-01-24	藤沢薬品工業株式会社	チアゾール化合物、その製造法およびそれを含有する医薬組成物
US4902695A (en) *	1989-02-13	1990-02-20	Eli Lilly And Company	Excitatory amino acid receptor antagonists
US5328925A (en) *	1989-02-22	1994-07-12	Novo Nordisk A/S	Piperidine compounds and their use
US5043345A (en) *	1989-02-22	1991-08-27	Novo Nordisk A/S	Piperidine compounds and their preparation and use
US5260311A (en) *	1989-02-22	1993-11-09	Novo Nordisk A/S	Piperidine compounds and their use
US5264444A (en) *	1989-02-22	1993-11-23	Novo Nordisk A/S	Piperidine compounds and use
EP0402056A3 (en) *	1989-06-06	1991-09-04	Beecham Group p.l.c.	Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
ATE136031T1 (de) *	1989-10-07	1996-04-15	Beecham Group Plc	Azabizyklische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US5200419A (en) *	1990-05-21	1993-04-06	Warner-Lambert Company	Substituted tetrazoles and derivatives thereof acting at muscarinic receptors
IE911994A1 (en) *	1990-07-03	1992-01-15	Akzo Nv	5-isothiazolamine derivatives
DK198590D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
USRE35822E (en) *	1990-08-21	1998-06-09	Novo Nordisk A/S	Heterocyclic compounds
US5376668A (en) *	1990-08-21	1994-12-27	Novo Nordisk A/S	Heterocyclic compounds
DK198390D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) *	1990-08-21	1995-05-23	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
US5527813A (en) *	1990-08-21	1996-06-18	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
DK198490D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
EP0561913B1 (en) *	1990-11-29	1998-04-01	Allergan, Inc.	Use of pyridine derivatives in the treatment of ocular hypertension
AU654013B2 (en) *	1991-03-13	1994-10-20	Regents Of The University Of Minnesota	2-hydroxy-3(4-iodophenyl)-1-(4-phenylpiperidinyl) propane
IE922270A1 (en) *	1991-07-26	1993-01-27	Akzo Nv	Pyrazole derivatives
US5641791A (en) *	1991-08-13	1997-06-24	Novo Nordisk A.S	Heterocyclic compounds and their preparation and use
US5175166A (en) *	1991-08-27	1992-12-29	The University Of Toledo	Muscarinic agonists
WO1993014089A1 (en) *	1992-01-13	1993-07-22	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
US5330994A (en) *	1992-03-24	1994-07-19	Warner-Lambert Company	Tetrahydropyridine isoxazoline derivatives
CA2146019A1 (en) *	1992-10-23	1994-05-11	Howard B. Broughton	Dopamine receptor subtype ligands
US5753683A (en) *	1993-08-19	1998-05-19	Novo Nordisk A/S	Antipsychotic method
US5612351A (en) *	1994-11-08	1997-03-18	Novo Nordisk A/S	Method of treating urinary bladder dysfunctions
US5668148A (en) *	1995-04-20	1997-09-16	Merck & Co., Inc.	Alpha1a adrenergic receptor antagonists
EP0835255A1 (en) *	1995-06-29	1998-04-15	Novo Nordisk A/S	Novel substituted azacyclic compounds
CZ287441B6 (en) *	1995-11-06	2000-11-15	Lundbeck & Co As H	Pharmaceutical preparation for treating traumatic lesion of brain
EP0910566B1 (en) *	1996-04-24	2003-09-17	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
US5733912A (en) *	1997-02-19	1998-03-31	Abbott Laboratories	7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
EP1014974B1 (en) *	1997-05-29	2004-08-11	H. Lundbeck A/S	Treatment of schizophrenia and psychosis
AR013096A1 (es) *	1997-07-01	2000-12-13	Lundbeck & Co As H	Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
JP2001518503A (ja) *	1997-10-02	2001-10-16	ハー・ルンドベック・アクチエゼルスカベット	５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジンの粒状調合物
PL366197A1 (en) *	1998-07-27	2005-01-24	Eli Lilly And Company	Treatment of anxiety disorders
AU6686700A (en) *	1999-08-23	2001-03-19	H. Lundbeck A/S	Treatment of urinary incontinence
US20030220371A1 (en) *	2000-04-12	2003-11-27	Kallander Lara S.	Compounds and methods
EP1373263B1 (en) *	2001-04-05	2004-10-27	Torrent Pharmaceuticals Ltd	Heterocyclic compounds for aging-related and diabetic vascular complications
US20030069597A1 (en) *	2001-10-10	2003-04-10	Scimed Life Systems, Inc.	Loading tool
CA2467749A1 (en)	2001-11-19	2003-05-30	Elan Pharmaceuticals, Inc.	(4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
AU2003296308A1 (en)	2002-12-18	2004-07-29	Bayer Cropscience Ag	N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
EP1581497A4 (en) *	2002-12-20	2009-03-18	Merck & Co Inc	INHIBITORS OF MITOTIC KINESINE
JP2007523202A (ja) *	2004-02-24	2007-08-16	ビオアクソン・テラプティーク・インコーポレーテッド	４置換ピペリジン誘導体
US20060224175A1 (en) *	2005-03-29	2006-10-05	Vrba Anthony C	Methods and apparatuses for disposition of a medical device onto an elongate medical device
CA2620333A1 (en)	2005-08-26	2007-03-01	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by pde inhibition
EP2314289A1 (en)	2005-10-31	2011-04-27	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
US7678808B2 (en)	2006-05-09	2010-03-16	Braincells, Inc.	5 HT receptor mediated neurogenesis
CA2651813A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
EP2068872A1 (en)	2006-09-08	2009-06-17	Braincells, Inc.	Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
EP2150543A2 (en) *	2007-04-24	2010-02-10	Solvay Pharmaceuticals B.V.	Heterocyclic compounds with affinity to muscarinic receptors
US8084473B2 (en)	2007-04-24	2011-12-27	Solvay Pharmaceuticals B.V.	Heterocyclic compounds with affinity to muscarinic receptors
EP2296471A4 (en)	2008-05-15	2012-03-14	Univ Toledo	MUSCARIC ACID AGONISTS AS COGNITIVE ENHANCERS
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
AU2010245596A1 (en) *	2009-05-07	2011-12-22	Torrent Pharmaceuticals Limited	Piperidine derivatives useful for treatment of diebetes
CN104086528A (zh)	2010-07-15	2014-10-08	拜耳知识产权有限责任公司	作为杀虫剂的新杂环化合物
BR112013009823A2 (pt)	2010-10-22	2016-07-05	Bayer Ip Gmbh	novos compostos heterocíclicos como pesticidas
WO2012149524A1 (en)	2011-04-29	2012-11-01	The University Of Toledo	Muscarinic agonists as enhancers of working memory and cognitive flexibility
CN103848850B (zh) *	2013-08-28	2016-03-23	沈阳东瑞精细化工有限公司	一种舒巴坦的制备方法
US10149856B2 (en)	2015-01-26	2018-12-11	BioAxone BioSciences, Inc.	Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10857157B2 (en)	2015-01-26	2020-12-08	BioAxone BioSciences, Inc.	Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10106525B2 (en)	2015-01-26	2018-10-23	BioAxone BioSciences, Inc.	Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US11198680B2 (en)	2016-12-21	2021-12-14	BioAxone BioSciences, Inc.	Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10537567B2 (en)	2017-07-11	2020-01-21	BioAxone BioSciences, Inc.	Kinase inhibitors for treatment of disease
WO2022067165A1 (en) *	2020-09-28	2022-03-31	Yale University	Selective agonists of 5-ht2a receptor and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2659739A (en)	1950-04-14	1953-11-17	Eastman Kodak Co	1-hydroxy-4-beta-cyanopropylamino-anthraquinone and process for preparing same
BE845612A (fr) *	1976-03-23	1977-02-28		Derives de tetrazole-5-carboxamide et leur preparation
US4431653A (en) *	1982-03-18	1984-02-14	Hoffmann-La Roche Inc.	Penicillanic acid derivatives
DE3421072A1 (de) *	1984-06-06	1985-12-12	Heinrich Mack Nachf., 7918 Illertissen	1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4650805A (en) *	1985-12-02	1987-03-17	Warner-Lambert Company	4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
NZ219646A (en) *	1986-03-27	1990-10-26	Merck Sharp & Dohme	Oxadiazole derivatives of azacyclics for treating cns disorders
GB8610432D0 (en) *	1986-04-29	1986-06-04	Akzo Nv	Amino-thiazole & oxazole derivatives
IL83275A (en) *	1986-09-08	1994-02-27	Novo Nordisk As	Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
IE63906B1 (en) *	1987-11-13	1995-06-14	Novo Nordisk As	Azabicyclic compounds and their preparation and use
EP0372125A1 (en) *	1988-11-08	1990-06-13	Akzo N.V.	Oxazole and thiazole derivatives

1987
- 1987-06-24 GB GB878714789A patent/GB8714789D0/en active Pending
1988
- 1988-05-27 EP EP88304899A patent/EP0296721B1/en not_active Expired - Lifetime
- 1988-05-27 ES ES88304899T patent/ES2056928T3/es not_active Expired - Lifetime
- 1988-05-27 DE DE88304899T patent/DE3881970T2/de not_active Expired - Lifetime
- 1988-05-30 IE IE163188A patent/IE61694B1/en not_active IP Right Cessation
- 1988-06-01 NZ NZ224868A patent/NZ224868A/en unknown
- 1988-06-03 IL IL86618A patent/IL86618A/xx not_active IP Right Cessation
- 1988-06-13 DK DK321688A patent/DK168600B1/da not_active IP Right Cessation
- 1988-06-17 ZA ZA884339A patent/ZA884339B/xx unknown
- 1988-06-22 CA CA000570135A patent/CA1340458C/en not_active Expired - Lifetime
- 1988-06-22 US US07/209,994 patent/US4866077A/en not_active Ceased
- 1988-06-23 AU AU18282/88A patent/AU615917B2/en not_active Expired
- 1988-06-23 NO NO882799A patent/NO174051C/no not_active IP Right Cessation
- 1988-06-23 FI FI883064A patent/FI93356C/fi active IP Right Grant
- 1988-06-24 PT PT87820A patent/PT87820B/pt not_active IP Right Cessation
- 1988-06-24 JP JP63155095A patent/JP2703268B2/ja not_active Expired - Lifetime
1989
- 1989-04-26 US US07/343,848 patent/US4925858A/en not_active Expired - Lifetime
1994
- 1994-08-18 HK HK84194A patent/HK84194A/xx not_active IP Right Cessation
1995
- 1995-03-08 HU HU95P/P00089P patent/HU210809A9/hu unknown
1996
- 1996-05-13 US US08/648,240 patent/USRE36374E/en not_active Expired - Lifetime
1997
- 1997-05-07 BR BR1100658-7A patent/BR1100658A/pt active IP Right Grant

Also Published As

Publication number	Publication date
FI93356B (fi)	1994-12-15
DE3881970D1 (de)	1993-07-29
NO882799L (no)	1988-12-27
AU615917B2 (en)	1991-10-17
CA1340458C (en)	1999-03-23
IL86618A0 (en)	1988-11-30
AU1828288A (en)	1989-01-05
NO174051C (no)	1994-03-09
IE61694B1 (en)	1994-11-16
IL86618A (en)	1992-07-15
US4925858A (en)	1990-05-15
HU210809A9 (en)	1995-08-28
FI883064A (fi)	1988-12-25
NZ224868A (en)	1990-07-26
NO882799D0 (no)	1988-06-23
EP0296721B1 (en)	1993-06-23
HK84194A (en)	1994-08-26
BR1100658A (pt)	1999-08-31
ES2056928T3 (es)	1994-10-16
ZA884339B (en)	1989-05-30
FI93356C (fi)	1995-03-27
EP0296721A3 (en)	1990-04-25
DK321688A (da)	1988-12-25
DK321688D0 (da)	1988-06-13
US4866077A (en)	1989-09-12
GB8714789D0 (en)	1987-07-29
PT87820B (pt)	1992-10-30
EP0296721A2 (en)	1988-12-28
PT87820A (pt)	1989-05-31
JPS6422869A (en)	1989-01-25
USRE36374E (en)	1999-11-02
IE881631L (en)	1988-12-24
JP2703268B2 (ja)	1998-01-26
NO174051B (no)	1993-11-29
DK168600B1 (da)	1994-05-02
DE3881970T2 (de)	1993-11-11

Publication	Publication Date	Title
FI883064A0 (fi)	1988-06-23	Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI880941A0 (fi)	1988-03-01	Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
FI92934B (fi)	1994-10-14	Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI90769C (fi)	1994-03-25	Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
FI882007A (fi)	1988-10-30	Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI880757A0 (fi)	1988-02-18	Menetelmä valmistaa terapeuttisesti vaikuttavia tyydytettyjä heterosyklisiä karboksamidijohdoksia
FI905941A (fi)	1991-06-07	Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI874459A0 (fi)	1987-10-09	Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI881223A (fi)	1988-09-18	Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
NO178619C (no)	1996-05-02	Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI94752C (fi)	1995-10-25	Menetelmä terapeuttisesti käyttökelpoisten propenonioksiimieettereiden valmistamiseksi
FI850654A0 (fi)	1985-02-15	Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi
FI880869A (fi)	1988-08-26	Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI93215C (fi)	1995-03-10	Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI884471A0 (fi)	1988-09-29	Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI104171B (fi)	1999-11-30	Menetelmä mono-N-alkyloitujen polyatsamakrosyklisten yhdisteiden valmistamiseksi
FI880467A (fi)	1988-08-05	Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI884910A (fi)	1989-04-28	Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI104075B1 (fi)	1999-11-15	Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI880716A0 (fi)	1988-02-16	Menetelmä terapeuttisesti käyttökelpoisten aryylipiperatsinyylialkyleenifenyylisubstituoitujen heterosyklisten yhdisteiden valmistamiseksi
FI893003A0 (fi)	1989-06-19	Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI98461B (fi)	1997-03-14	Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI891144A (fi)	1989-09-10	Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
FI903077A0 (fi)	1990-06-19	Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI880190A0 (fi)	1988-01-18	Menetelmä valmistaa terapeuttisesti vaikuttavia tetrahydrofuraanijohdoksia

Legal Events

Date	Code	Title	Description
1994-11-16	BB	Publication of examined application
2004-08-31	FG	Patent granted	Owner name: H. LUNDBECK A/S